Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies.
暂无分享,去创建一个
Bryan Briney | Ian A Wilson | Dennis R Burton | William R Schief | Daniel W. Kulp | D. Burton | I. Wilson | W. Schief | B. Briney | A. Ward | R. Sanders | M. V. van Gils | C. Cottrell | J. Torres | G. Ozorowski | D. Sok | S. Menis | D. Kulp | Matthew S Macauley | M. Pauthner | Gabriel Ozorowski | Daniel W Kulp | Matthias Pauthner | Devin Sok | Sergey Menis | Andrew B Ward | L. McCoy | Jessica Hsueh | Terrence Messmer | J. Voss | Bryan S. Briney | James E Voss | Laura E McCoy | Jessica Hsueh | Rogier W Sanders | Marit J van Gils | Christopher A Cottrell | Terrence Messmer | Jonathan L Torres
[1] J. Benschop,et al. Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking , 2013, Journal of Virology.
[2] Wayne C Koff,et al. Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. , 2014, Immunity.
[3] S. Reddy,et al. Systematic Characterization and Comparative Analysis of the Rabbit Immunoglobulin Repertoire , 2014, PloS one.
[4] John P. Moore,et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.
[5] L. Morris,et al. Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes , 2013, PLoS pathogens.
[6] Lynn Morris,et al. Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape , 2012, Nature Medicine.
[7] John R Mascola,et al. Antibody responses to envelope glycoproteins in HIV-1 infection , 2015, Nature Immunology.
[8] A. Ward,et al. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer , 2016, Science.
[9] Robin A. Weiss,et al. Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1 , 2014, PLoS pathogens.
[10] S. Zolla-Pazner,et al. Characterization of Structural Features and Diversity of Variable-Region Determinants of Related Quaternary Epitopes Recognized by Human and Rhesus Macaque Monoclonal Antibodies Possessing Unusually Potent Neutralizing Activities , 2011, Journal of Virology.
[11] L. Morris,et al. Virological features associated with the development of broadly neutralizing antibodies to HIV-1. , 2015, Trends in microbiology.
[12] John P. Moore,et al. Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer , 2015, PLoS pathogens.
[13] Lynn Morris,et al. Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection , 2009, PLoS pathogens.
[14] James C Paulson,et al. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. , 2014, Immunity.
[15] Anchi Cheng,et al. Automated molecular microscopy: the new Leginon system. , 2005, Journal of structural biology.
[16] B. Korber,et al. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses. , 2015, Cell host & microbe.
[17] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[18] Lynn Morris,et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies , 2015, Nature Medicine.
[19] D. Montefiori,et al. Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop , 2015, PloS one.
[20] Barbra A. Richardson,et al. Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant , 2006, Journal of Virology.
[21] Daniel W. Kulp,et al. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site , 2015, PLoS pathogens.
[22] B. Korber,et al. Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection , 2014, AIDS.
[23] Saikat Banerjee,et al. Detailed characterization of antibody responses against HIV-1 group M consensus gp120 in rabbits , 2014, Retrovirology.
[24] David Nemazee,et al. Rational immunogen design to target specific germline B cell receptors , 2012, Retrovirology.
[25] Dennis R Burton,et al. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design. , 2016, Annual review of immunology.
[26] Daniel W. Kulp,et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice , 2015, Cell.
[27] Hanneke Schuitemaker,et al. Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[28] John P. Moore,et al. Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes , 2015, Cell.
[29] Tongqing Zhou,et al. Structure and immune recognition of trimeric prefusion HIV-1 Env , 2014, Nature.
[30] R. Doms,et al. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans. , 2015, Vaccine.
[31] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[32] Robyn L Stanfield,et al. Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. , 2015, Immunity.
[33] J. Mascola,et al. Diverse Antibody Genetic and Recognition Properties Revealed following HIV-1 Envelope Glycoprotein Immunization , 2015, The Journal of Immunology.
[34] T. Kepler,et al. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. , 2016, Cell reports.
[35] S. Gnanakaran,et al. Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways , 2009, PLoS pathogens.
[36] G. Debnath,et al. D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .
[37] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[38] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[39] R. Weiss,et al. Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization , 2012, The Journal of experimental medicine.
[40] J. Mascola,et al. Single-Cell and Deep Sequencing of IgG-Switched Macaque B Cells Reveal a Diverse Ig Repertoire following Immunization , 2014, The Journal of Immunology.
[41] Florian Klein,et al. Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy , 2014, Cell.
[42] T. Wrin,et al. Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate , 2013, PloS one.
[43] R. Sanders,et al. In vivo protection by broadly neutralizing HIV antibodies. , 2014, Trends in microbiology.
[44] Terri Wrin,et al. Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors , 2010, Journal of Virology.
[45] William R. Schief,et al. Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV , 2014, Science Translational Medicine.
[46] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[47] J. Mascola,et al. Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates , 2010, The Journal of experimental medicine.
[48] David Nemazee,et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen , 2015, Science.
[49] J. Mascola,et al. High-Resolution Definition of Vaccine-Elicited B Cell Responses Against the HIV Primary Receptor Binding Site , 2012, Science Translational Medicine.
[50] J. Mascola,et al. HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies , 2015, Journal of Virology.
[51] D. Montefiori,et al. A Novel Rabbit Monoclonal Antibody Platform To Dissect the Diverse Repertoire of Antibody Epitopes for HIV-1 Env Immunogen Design , 2013, Journal of Virology.
[52] Christopher Irving,et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.
[53] Daphne Koller,et al. The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies , 2013, PLoS pathogens.
[54] John P. Moore,et al. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity , 2015, Journal of Virology.
[55] J. Binley,et al. Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination , 2008, Journal of Virology.